Overview of nebuliser treatment

Thorax

Volumn 52, Issue SUPPL. 2, 1997, Pages

  Muers, M F ^a  

^a Killingbeck Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CROMOGLYCATE DISODIUM; LOCAL ANESTHETIC AGENT; MUCOLYTIC AGENT; OPIATE AGONIST; STEROID;

AIRWAY OBSTRUCTION; CLINICAL PRACTICE; COUGHING; DYSPNEA; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG INFECTION; MEDICAL NEBULIZER; NEBULIZATION; PRIORITY JOURNAL; REVIEW;

EID: 0030927887     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.2008.s25     Document Type: Review

References (36)

1. Shorter Oxford English Dictionary: 3rd edn. Oxford: Clarendon Press, 1950.
2. Mathu DL. Pulmonary tuberculosis. Its aetiology and treatment. London: Balliere Tindall and Fox, 1922: 266-9.
3. Mercer TT. Production of therapeutic aerosols: principles and techniques. Chest 1981;80:S813-7.
4. Wright BM. A new nebuliser. Lancet 1958;ii:24.
5. Hosker HSR, Teale C, Greenstone MA, Muers MF. Assessment and provision of home nebulizers for chronic obstructive disease (COPD) in the Yorkshire region of the UK. Respir Med 1994;89:47-52.
6. Caldwell NA, Milroy R, McCabe J, Banham SW, Moran F. An audit of nebulization technique in a major teaching hospital: scope for improvement. Pharm J 1991;247:706-8.
7. Brandli G. Maintenance and servicing of nebulizers. Eur Respir Rev 1994;4(Suppl 18):102-3.
8. Alderson PO, Bielo DR, Gottshalk A, Hoffer PB, Kroop SA, Lee ME, et al. Tc-99m DTPA aerosols and radioactive gases compared as adjuncts to perfusion scintigraphy in patients with suspected pulmonary embolism. Radiology 1984;153:515-21.
9. Pavia D, Sutton PP, Agnew JE, Lopez Vidriero MT, Newman SP, Clarke SW. Measurement of bronchial mucociliary clearance. Eur J Respir Dis 1983;127(Suppl):41-56.
10. Barrowcliffe MP, Jones JG. Solute permeability of the alveolar capillary barrier. Thorax 1987;42:1-10.
11. European Respiratory Society: Airway responsiveness: standardised challenge testing with pharmacological physical and sensitising stimuli in adults. Working Party Report. Eur Respir J 1993;6(Suppl 16):53-83.
12. Bigby TD, Margolskee D, Curtis JL, Michael PF, Sheppard D, Hadley WK, et al. The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1986;133:515-8.
13. Conway JH, Halson P, Moore E, Hashish A, Bailey AG, Nassim M, et al. Multi-modality imaging: the use of single photon emission computed tomography and magnetic resonance imaging to assess regional intra-pulmonary deposition of nebulized aerosols. J Aerosol Med 1995;8: 341-56.
14. Morgan MDL, Singh BV, Frame MH, Williams SJ. Terbutaline aerosol given through pear spacer in acute severe asthma. BMJ 1982;285:849-50.
15. Freelander S, Van Asperen N. Nebuhaler vs nebulizer in children with acute asthma. BMJ 1984;288:1873-4.
16. American Thoracic Society. Snowbird workshop on standardisation of spirometry. Am Rev Respir Dis 1979;119: 831-8.
17. Dales RE, Spitzer WO, Tousigmant P, Schecter M, Suissa S. Clinical interpretation of airway response to a bronchodilator: epidemiologic considerations. Am Rev Respir Dis 1988;138:317-20.
18. 1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax 1987; 42:487-90.
19. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18.
20. European Respiratory Society. Standardised lung function testing. Eur Respir J 1993;6(Suppl 16):5-40.
21. Dekker FW, Schrier AC, Sterk PJ, Dijkman JH. Validity of peak expiratory flow measurement in assessing reversibility of air flow obstruction. Thorax 1992;47:162-6.
22. Mitchell DM, Gildeh P, Rehahn M, Diamond AH, Collins JV. Effect of prednisolone in chronic airflow limitation. Lancet 1984;ii:193-6.
23. Wardman AG. The diagnosis and treatment of adults with obstructive airways disease in general practice. MD thesis, University of Edinburgh, 1985.
24. Goldman JM, Teale C, Muers MF. Simplifying the assessment of patients with chronic airflow limitation for home nebulizer therapy. Respir Med 1992;86:33-8.
25. Weir DC, Gove RI, Robertson AS, Sherwood Burge P. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax 1990;45:112-7.
26. Jones PW. Quality of life measurement for patients with diseases of the airways. Thorax 1992;47:676-82.
27. Camps PWL. A note on the inhalation treatment of asthma. Guy's Hosp Rep 1929;79:496-8.
28. Rogers DR, Ganderton D, eds. British Association for Lung Research: workshop report. Determining equivalence of inhaled medications. Respir Med 1994;89:253-61.
29. Dennis JH, Stenton SC, Beach JR, Avery AJ, Walters EH, Hendrick DJ. Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output. Thorax 1990;45:728-32.
30. Alvine GF, Rodgers P, Fitzsimmons KM, Ahrens RC. Disposable jet nebulizers: how reliable are they? Chest 1992; 101:316-9.
31. Smith EC, Denver J, Kendrick AH. Comparison of 23 nebulizer/compressor combinations for domiciliary use. Eur Respir J 1995;8:1214-21.
32. Craig IR, Riley MR, Cooke NJ. Prescribing of nebulized bronchodilators - can we change bad habits? Respir Med 1989;83:333-4.
33. Vermiere P. European trends in inhalation therapy. Eur Respir Rev 1994;4(Suppl 18):89-91.
34. American Respiratory Care Foundation and the American Association for Respiratory Care. Aerosol consensus statement. Chest 1991;100:1106-9.
35. Quality guidelines: nebulizers in home health care. TNO Prevention and Health, Division of Technology and Health Care, Liddem, The Netherlands, 1994.
36. Muers MF. The rational use of nebulizers in clinical practice. Eur Respir Rev 1997 (in press).